Status | Study |
Recruiting |
Study Name: Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease Condition: Kawasaki Disease Date: 2014-06-28 Interventions: Drug: Anakinra First two doses IV followed by SQ dosing |
Recruiting |
Study Name: Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease Condition: Kawasaki Disease Coronary Aneurysm Date: 2013-04-26 Interventions: Drug: Doxycycline The interven |
Completed |
Study Name: Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease Condition: Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin Date: 2012-05-09 Interventions: Drug: TA-650 TA-650 at 5 mg pe |
Completed |
Study Name: Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease Condition: Kawasaki Disease Date: 2012-01-25 Interventions: Drug: immunoglobulin G Intravenously administer a single dose of the product (2g/kg) for at least 12 hou |
Recruiting |
Study Name: Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease Condition: Kawasaki Disease Date: 2011-09-21 Interventions: Other: Cardiac evaluation complete cardiac evaluation with |
Recruiting |
Study Name: Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities Condition: Kawasaki Disease Date: 2011-09-06 Interventions: Drug: Atorvastatin Atorvastatin dose titration to maximum tolerated dose (once daily for 6 weeks) |
Recruiting |
Study Name: Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki Disease Condition: Kawasaki Disease Aneurysm, Coronary Date: 2010-06-28 Interventions: Drug: Atorvastatin 10 mg qd x1 year Other Name: Lipi |
Completed |
Study Name: Real Time Myocardial Contrast Echocardiography and Dobutamine Stress Perfusion Magnetic Resonance Imaging Condition: Kawasaki Disease Heart Disease Date: 2009-03-12 |
Active, not recruiting |
Study Name: Etanercept in Kawasaki Disease Condition: Mucocutaneous Lymph Node Syndrome Kawasak Date: 2009-02-10 Interventions: Drug: Etanercept etanercept 0. |
Completed |
Study Name: Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki Disease Condition: Kawasaki Disease Date: 2008-09-25 Interventions: Drug: Infliximab 5 mg/kg IV ov |